These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 32578710)
1. Mucocutaneous leishmaniasis in a cocaine user: diagnostic and therapeutic knowledge. Sbroglio LL; Maiolini VM; Rabelo IMMA; Giraldelli GA; Tuccori LP; Cunha RG Rev Soc Bras Med Trop; 2020; 53():e20200040. PubMed ID: 32578710 [TBL] [Abstract][Full Text] [Related]
2. Refractory mucocutaneous leishmaniasis resolved with combination treatment based on intravenous pentamidine, oral azole, aerosolized liposomal amphotericin B, and intralesional meglumine antimoniate. Basile G; Cristofaro G; Locatello LG; Vellere I; Piccica M; Bresci S; Maggiore G; Gallo O; Novelli A; Di Muccio T; Gramiccia M; Gradoni L; Gaiera G; Bartoloni A; Zammarchi L Int J Infect Dis; 2020 Aug; 97():204-207. PubMed ID: 32505874 [TBL] [Abstract][Full Text] [Related]
3. Oral leishmaniasis in a HIV-positive patient. Report of a case involving the palate. Milián MA; Bagán JV; Jiménez Y; Pérez A; Scully C Oral Dis; 2002 Jan; 8(1):59-61. PubMed ID: 11936458 [TBL] [Abstract][Full Text] [Related]
4. Disseminated mucocutaneous leishmaniasis resulting from chronic use of corticosteroid. Motta AC; Arruda D; Souza CS; Foss NT Int J Dermatol; 2003 Sep; 42(9):703-6. PubMed ID: 12956682 [TBL] [Abstract][Full Text] [Related]
5. Case Report: First Report of Mucocutaneous Leishmaniasis in Algeria: Observations from a Case Report. Seklaoui N; Izri A; Tablit I; Chergou M; Hamrioui B; Akhoundi M Am J Trop Med Hyg; 2024 Aug; 111(2):377-379. PubMed ID: 38861965 [TBL] [Abstract][Full Text] [Related]
6. Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis. Goyonlo VM; Vahabi-Amlashi S; Taghavi F Int J Parasitol Drugs Drug Resist; 2019 Dec; 11():177-179. PubMed ID: 31492621 [TBL] [Abstract][Full Text] [Related]
7. Successful response to liposomal amphotericin B in mucosal leishmaniasis in glans resistant to intralesional pentavalent. Aguayo-Carreras P; Cuenca-Barrales C; Perez-López I; Ruiz-Villaverde R; Tercedor-Sanchez J Int J Dermatol; 2019 Jul; 58(7):e137-e138. PubMed ID: 30883705 [No Abstract] [Full Text] [Related]
8. Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World. Zaraa I; Karoui S; Osman AB J Dermatol; 2012 Feb; 39(2):201-3. PubMed ID: 21950659 [No Abstract] [Full Text] [Related]
9. Clinical characteristics of human Leishmania braziliensis braziliensis infections. Llanos Cuentas EA; Cuba CC; Barreto AC; Marsden PD Trans R Soc Trop Med Hyg; 1984; 78(6):845-6. PubMed ID: 6533860 [No Abstract] [Full Text] [Related]
10. Electrocardiographic alterations during treatment of mucocutaneous leishmaniasis with meglumine antimoniate and allopurinol. Antezana G; Zeballos R; Mendoza C; Lyevre P; Valda L; Cardenas F; Noriega I; Ugarte H; Dedet JP Trans R Soc Trop Med Hyg; 1992; 86(1):31-3. PubMed ID: 1566297 [TBL] [Abstract][Full Text] [Related]
11. [A case of mucocutaneous leishmaniasis treated with success with a low dose of pentavalent antimonial]. Amato VS; de Oliveira LS; Silva AC; Machado FR; Amato JG; Nicodemo AC; Amato Neto V Rev Soc Bras Med Trop; 1998; 31(2):221-4. PubMed ID: 9608241 [TBL] [Abstract][Full Text] [Related]
12. Mucocutaneous leishmaniasis masquerading as Wegener granulomatosis. Brahn E; Pegues DA; Yao Q; Craft N J Clin Rheumatol; 2010 Apr; 16(3):125-8. PubMed ID: 20375822 [TBL] [Abstract][Full Text] [Related]
13. A 33-year-old male farmer with progressive gingival swelling and bleeding. Azizi T; Sadeghipour A; Roohi A; Nilipour Y Ann Saudi Med; 2005; 25(3):262, 270-1. PubMed ID: 16119532 [No Abstract] [Full Text] [Related]
14. Simultaneous occurrence of cutaneous and mucocutaneous leishmaniasis caused by different genotypes of Leishmania (Viannia) braziliensis. Hoyos CL; Quipildor M; Bracamonte E; Lauthier JJ; Cajal P; Uncos A; Korenaga M; Hashiguchi Y; Barroso PA; Marco JD J Dermatol; 2019 Sep; 46(9):e320-e322. PubMed ID: 30938461 [No Abstract] [Full Text] [Related]
15. Leishmaniasis in the genital area. Cabello I; Caraballo A; Millan Y Rev Inst Med Trop Sao Paulo; 2002; 44(2):105-7. PubMed ID: 12048548 [TBL] [Abstract][Full Text] [Related]
16. A chronic mutilating rhinopathy with a delayed diagnosis of mucocutaneous leishmaniasis. Karimbil SK; Kumari S; Celine MI; Joy A Int J Dermatol; 2010 Apr; 49(4):426-9. PubMed ID: 20465699 [TBL] [Abstract][Full Text] [Related]
17. Lip leishmaniasis: a case series with molecular identification and literature review. Mohammadpour I; Motazedian MH; Handjani F; Hatam GR BMC Infect Dis; 2017 Jan; 17(1):96. PubMed ID: 28122496 [TBL] [Abstract][Full Text] [Related]
18. [A case of urticaria during pentavalent antimony use in a patient with mucous leishmaniasis]. Oliveira MR; Marsden PD Rev Soc Bras Med Trop; 1995; 28(3):287. PubMed ID: 7480927 [No Abstract] [Full Text] [Related]
19. Tongue Nodule as Primary Manifestation of American Cutaneous Leishmaniasis in an Immunocompetent Patient. Botelho MCB; Ferreira LL; Fikaris S; Prado-Ribeiro AC; Soubhia AMP; Biasoli ER; Miyahara GI; Bernabé DG Head Neck Pathol; 2021 Sep; 15(3):1069-1073. PubMed ID: 33372239 [TBL] [Abstract][Full Text] [Related]
20. [A fatal case of mucocutaneous leishmaniasis after pentavalent antimonial use]. Oliveira MC; Amorim RF; Freitas Rde A; Costa Ade L Rev Soc Bras Med Trop; 2005; 38(3):258-60. PubMed ID: 15895180 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]